New Delhi, Jul 13 (PTI) Jubilant Pharma Holdings on Wednesday said it has signed an agreement with Standard Chartered Bank for a five-year loan of USD 400 million, about Rs 3,186 crore.

Majority of the amount will be used for repayment of existing term loan and debt bonds, the company said in a regulatory filing.

Also Read | ITR Filing for FY 2021-22 (AY 2022-23): Know Last Date to File Income Tax Return for Individuals, HUF, Firms And Penalty If You Miss Deadline.

While the term loan and bonds aggregate to USD 350 million, about Rs 2,787 crore, the company is raising another tranche of USD 50 million (about Rs 400 crore) for capital expenditure.

"Jubilant Pharmova Limited's wholly-owned subsidiary Jubilant Pharma Limited today announced that its subsidiary Jubilant Pharma Holdings Inc (JPHI) has entered in an agreement with Standard Chartered Bank for a five-year loan facility for repayment of existing term loan and bonds aggregating USD 350 million and additional tranche of USD 50 million for future growth capex," the company said.

Also Read | 5 Leading Online NEET Coaching Institutes Providing Quality Learning and Mentorship.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)